BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Editas Medicine

Editas Medicine logo

Founded
2013
Geography
United States of America based
Funding
$210 M

Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Technologies

CRISPR Startups   Gene Therapy Startups  


Posts Mentioning This Company

Biopharma Insights

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet